Haona Bao | Medicinal Chemistry | Best Researcher Award

Haona Bao | Medicinal Chemistry | Best Researcher Award

Ms. Haona Bao, The Ohio State Univerisity, United States

Ms. Haona Bao is a dynamic Ph.D. candidate in Food Science and Technology at The Ohio State University ๐ŸŽ“. With academic roots at UC Davis and Tennessee State University, her research spans vibrational spectroscopy, food quality, and fibromyalgia diagnostics ๐Ÿงช. She has published impactful studies on encapsulation, essential oils, and Raman-based detection in top journals ๐Ÿ“š. As a teaching assistant, lab safety manager, and award-winning presenter ๐Ÿ†, she excels in scientific communication and leadership. Haona combines analytical skills, regulatory expertise, and creativity to shape the future of food safety and health innovation ๐ŸŒพ๐Ÿ”ฌ.

Publication Profile

Google Scholar

Education

Ms. Haona Bao is an accomplished scholar with a strong academic foundation in food science. She is currently pursuing her Ph.D. in Food Science and Technology at The Ohio State University (expected August 2025) ๐Ÿงช. She earned her Master of Science in Food and Animal Science from Tennessee State University between 2019 and 2021 ๐Ÿ“๐Ÿฅผ. Her academic journey began at the University of California, Davis, where she obtained her Bachelor of Science in Food Science and Technology in 2019 ๐Ÿ‡๐Ÿ”ฌ. Her diverse educational background reflects a deep commitment to advancing innovation in food systems and safety ๐ŸŒฑ๐Ÿ“˜.

Experience

Ms. Haona Bao has extensive research experience in food science and technology. At The Ohio State University (2022โ€“present), she serves as a Doctoral Research Assistant, applying vibrational spectroscopy and multivariate analysis for food quality, adulteration detection, and beer evaluation ๐Ÿบ๐Ÿ“Š. She also explores metabolomics for fibromyalgia diagnosis ๐Ÿง ๐Ÿงฌ. As a Teaching Assistant, she supports lab-based courses and student learning ๐Ÿ‘ฉโ€๐Ÿซ๐Ÿ“. In her role as Lab Safety Manager, she ensures chemical safety and compliance ๐Ÿงฏโš—๏ธ. At Tennessee State University (2019โ€“2021), she developed polymer-based encapsulation, led poultry trials, and contributed to novel packaging innovations.

Awards

Ms. Haona Bao has obtained key certifications that strengthen her expertise in food safety and regulatory compliance. In July 2020, she completed Advanced HACCP and Preventive Controls Training from the Food Safety Net Services (FSNS) ๐Ÿงผ๐Ÿงช, equipping her with in-depth knowledge of hazard analysis and critical control points. Earlier, in October 2019, she earned certification in Preventive Controls for Human Food from the Food Safety Preventive Control Alliance (FSPCA) ๐Ÿฅซ๐Ÿ”. These credentials highlight her commitment to ensuring safe food production processes and maintaining high industry standards in quality assurance and public health ๐Ÿ…๐ŸŒ.

Research Focus

Ms. Haona Bao specializes in Food Science and Analytical Chemistry, with a strong research focus on vibrational spectroscopy, metabolomics, and encapsulation technologies ๐Ÿงช๐ŸŒฟ. Her work bridges food quality control, functional ingredient delivery, and health diagnostics. She applies advanced spectroscopic tools like FT-IR, FT-MIR, and SERS for rapid, non-invasive diagnosis of conditions like fibromyalgia and long COVID ๐Ÿง โšก. Additionally, she explores natural polymers and essential oils in encapsulation for food and health applications ๐ŸŒฐ๐Ÿงด. Her cross-disciplinary efforts connect food safety, health monitoring, and chemical fingerprinting, making impactful contributions to nutraceuticals, rheumatology, and food authentication ๐Ÿ“Š๐Ÿท.

Publication Top Notes

Application of yellow mustard mucilage in encapsulation of essential oils and polyphenols using spray drying

Rapid biomarker-based diagnosis of fibromyalgia syndrome and related rheumatologic disorders by portable FT-IR spectroscopic techniques

Metabolic fingerprinting for the diagnosis of clinically similar long COVID and Fibromyalgia using a portable FT-MIR spectroscopic combined with chemometrics

Early diagnosis of fibromyalgia using surface-enhanced raman spectroscopy combined with chemometrics

Portable mid-infrared spectroscopy combined with chemometrics to diagnose fibromyalgia and other rheumatologic syndromes using rapid volumetric absorptive microsampling

Authentication and Quality Control of Distilled Spirits by Vibrational Spectroscopy

Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Heba Abdelmegeed | Medicinal Chemistry | Best Researcher Award

Dr. Heba Abdelmegeed, National Research Centre, Egypt

Dr. Heba Abdelmegeed is a senior researcher at the Chemistry of Natural Compounds Department, National Research Centre, Cairo, Egypt. ๐ŸŽ“ She earned her Ph.D. in Immunology (Magna Cum Laude) from Technische Universitรคt Dresden, Germany, and a Masterโ€™s in Pharmaceutical Sciences from Hokkaido University, Japan. With expertise in immunology, molecular biology, and cancer biology, she has authored impactful research on cancer therapeutics and immunomodulation. ๐Ÿงช Her diverse academic journey spans Germany, Japan, and Egypt, with multiple publications, awards, and international conference contributions. Driven by scientific curiosity, she continues to explore cutting-edge innovations in cancer biology and immunological research.

Publication Profile

Google Scholar

Education

Dr. Heba Abdelmegeed is a distinguished immunologist with a rich academic journey across three continents. She earned her Ph.D. in Immunology (magna cum laude) from the Technische Universitรคt Dresden, Germany ๐Ÿ‡ฉ๐Ÿ‡ช, where her research focused on the activation-dependent rearrangement of macrophage lipid metabolism. Prior to that, she completed her M.Sc. in Pharmaceutical Sciences at Hokkaido University, Japan ๐Ÿ‡ฏ๐Ÿ‡ต, exploring innovative approaches to activate iNKT cells using ฮฑ-GalCer liposomes and interleukin 12. Her academic path began in Egypt ๐Ÿ‡ช๐Ÿ‡ฌ, graduating with honors from Ain Shams University with a Bachelor’s in Pharmaceutical Sciences.

Experience

Dr. Heba Abdelmegeed is a dedicated researcher with a diverse and global professional background in pharmaceutical sciences. Since August 2020, she has served as a Senior Researcher at the Chemistry of Natural Compounds Department, NRC, Egypt ๐Ÿ‡ช๐Ÿ‡ฌ. Previously, she was a Ph.D. candidate at the Technical University of Dresden, Germany ๐Ÿ‡ฉ๐Ÿ‡ช, from 2015 to 2020. She also held the role of Assistant Researcher at NRC and was a Masterโ€™s candidate at Hokkaido University, Japan ๐Ÿ‡ฏ๐Ÿ‡ต. Her career began as a Quality Control Analyst at NODCAR, reflecting her strong foundation in drug analysis and research.

Research Focus

Dr. Heba Abdelmegeedโ€™s research primarily focuses on pharmacology, medicinal chemistry, and cancer biology ๐Ÿงช๐Ÿ”ฌ. Her work includes developing novel anti-cancer compounds, such as quinoline and pyridine derivatives, targeting tubulin polymerization and cyclin-dependent kinases to inhibit tumor growth ๐ŸŽฏ๐Ÿ’Š. She also explores nanoparticle drug delivery systems for enhanced antimicrobial and wound healing effects ๐Ÿงซ๐Ÿฉน. Additionally, Dr. Abdelmegeed investigates inflammation, mitochondrial function, and lipid metabolism in cancer and endocrine disorders ๐Ÿ”ฅ๐Ÿฆ โš™๏ธ. Her multidisciplinary approach bridges molecular biology, synthetic chemistry, and computational studies to advance therapeutic strategies against cancer and infectious diseases.

Publication Top Notes

In Vivo Inverse Correlation in the Activation of Natural Killer T Cells Through Dual-Signal Stimulation via a Combination of ฮฑ-Galactosylceramideโ€“Loaded Liposomes andย โ€ฆ

Succinate mediates inflammation-induced adrenocortical dysfunction

Coumarins: quorum sensing and biofilm formation inhibition

New heterocycles from dehydroacetic acid (DHA). Synthesis, antimicrobial activity, DNA gyrase inhibition, antioxidant activity, and molecular docking study

Chitosan nanoparticles of new chromone-based sulfonamide derivatives as effective anti-microbial matrix for wound healing acceleration

Synthetic Analogs of Marine Alkaloid Aplysinopsin Suppress Anti-Apoptotic Protein BCL2 in Prostate Cancer

Obesity-associated lipidomic remodeling of the adrenal gland indicates an important role of the FADS2-arachidonic acid axis in adrenocortical hormone production

INFLAMMATIONโ€“INDUCED DOWNREGULATION OF SUCCINATE DEHYDROGENASE REGULATES ADRENOCORTICAL FUNCTION

Exploring the antitumor potential of novel quinoline derivatives via tubulin polymerization inhibition in breast cancer; design, synthesis and molecular docking

Mitochondria in cancer: a comprehensive review, bibliometric analysis, and future perspectives

Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor

Yan Zhang | Medicinal Chemistry | Best Researcher Award

Yan Zhang | Medicinal Chemistry | Best Researcher Award ย 

Assoc. Prof. Dr. Yan Zhang, Hospital of Stomatology, Jilin University, China

Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, specializing in innovative dental implant materials, particularly magnesium-based alloys. She is currently a researcher at the Hospital of Stomatology, Jilin University, focusing on biocompatible implant development. With over 10 SCI-indexed publications, her work on the Nd-modified alloy ZNdK610 shows enhanced osteogenic potential. Dr. Zhang has completed three research projects and is actively pursuing translational research and industry collaborations. Though she has no patents or books yet, her pioneering research continues to push boundaries in implant material science.

Publication Profile

Scopus

Education

Assoc. Prof. Dr. Yan Zhang holds a Ph.D. in Stomatology from Jilin University, with a research focus on innovative implant materials, particularly the application of magnesium alloys ๐Ÿงช๐Ÿฆท. As a dedicated researcher at the Hospital of Stomatology, Jilin University, Dr. Zhang is actively involved in developing biocompatible materials to improve dental implant performance. Her work aims to enhance osseointegration and long-term implant success through advanced biomaterials ๐Ÿ”ฌ๐Ÿ’ก. With over 10 SCI-indexed publications, she has significantly contributed to the field of dental biomaterials, driving progress in implant technology and patient care ๐Ÿ“š๐Ÿ‘ฉโ€โš•๏ธ.

Professional Memberships

Assoc. Prof. Dr. Yan Zhang is currently not affiliated with any professional memberships or academic societies โŒ๐Ÿ“‹. Despite this, her dedication to advancing dental implant technology through independent research remains unwavering ๐Ÿ”ฌ๐Ÿฆท. Her work at the Hospital of Stomatology, Jilin University, continues to make meaningful contributions to the field, particularly in the development of magnesium alloy-based implant materials โš™๏ธ๐Ÿงช. While she may not hold formal memberships, her impactful research, numerous SCI-indexed publications, and commitment to scientific innovation speak volumes about her professional standing and influence in the stomatology community ๐Ÿ“–๐Ÿ’ผ.

Research Focus

Assoc. Prof. Dr. Yan Zhang specializes in Periodontal Regeneration and Tissue Engineering. Their research primarily focuses on how biological factors like Concentrated Growth Factor (CGF) exudate influence the healing and proliferation of human periodontal ligament cells, especially under inflammatory conditions such as those involving TNF-ฮฑ (tumor necrosis factor-alpha). This work is crucial in understanding and improving treatments for periodontal diseases by promoting tissue repair and regeneration. Dr. Zhangโ€™s research bridges cell biology, inflammation, and regenerative medicine to develop innovative therapies for oral health.

Publication Top Notes

Concentrated growth factor exudate enhances the proliferation of human periodontal ligament cells in the presence of TNF-ฮฑ

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

TRAN CHAUMYTHANH | Medicinal Chemistry | Young Scientist Award

Dr. TRAN CHAUMYTHANH, DUYTAN UNIVERSITY, Vietnam

Dr. Chaumy Thanh Tran is a dedicated medical doctor and Ph.D. holder from Hue University of Medicine and Pharmacy, Vietnam. Her groundbreaking research integrates online medical databases and sequencing technologies to explore biomarkers for early disease detectionโ€”including diabetes, cardiovascular diseases, stroke, and cancers. She focuses on gene-targeted drug development and CRISPR/Cas9 gene editing. From 2023 to 2025, her work on LncRNA/CircRNA/miRNA/gene/protein-drug networks stands out as a vital resource for molecular biology. With several publications in high-impact journals (SCI, Scopus), Dr. Tran’s innovations aim to elevate human health and therapeutic strategies worldwide.

Publication Profile

Scopus

Education

Dr. Tran Chaumythanh ๐ŸŽ“ is a dedicated medical professional with a strong academic foundation in medicine. She earned her Medical Doctor (MD) degree from Hue University of Medicine and Pharmacy, Vietnam ๐Ÿฅ, where she also pursued and completed her Doctorate (Ph.D.) in the same esteemed institution ๐Ÿ“š. With a commitment to advancing healthcare and medical education, Dr. Chaumythanh combines clinical expertise with academic excellence, contributing to both patient care and research innovation. Her journey reflects a passion for medicine and a continuous drive for knowledge, shaping her as a respected figure in Vietnamโ€™s medical and academic communities ๐ŸŒŸ.

Research Experience

Dr. Tran Chaumythanh ๐Ÿ”ฌ is at the forefront of cutting-edge research in molecular biology, leveraging online medical databases and next-generation sequencing technologies to advance modern disease studies. Her work focuses on identifying early biomarkers ๐Ÿงฌ for diabetes, cardiovascular diseases, strokes, and cancers. She also explores gene targets for novel drug development ๐Ÿ’Š and utilizes gene-editing tools like CRISPR/Cas9 to correct harmful mutations ๐Ÿงช. From 2023 to 2025, her investigations delve into the complex interaction networks of LncRNA, CircRNA, miRNA, genes, and proteins, aiming to build a comprehensive knowledge base for future therapeutic innovations and precision medicine ๐Ÿ”—๐Ÿ“ˆ.

Research Focus

Dr. Tran ChaumyThanhโ€™s research primarily centers on bioinformatics-driven analysis of latent tuberculosis (TB), with a strong focus on gene and miRNA regulatory networks, immune cell infiltration, and potential drug-gene interactions. Utilizing microarray data analysis, molecular docking, and molecular dynamics simulation, her work aims to identify novel therapeutic targets and unravel complex host-pathogen interactions. This multidisciplinary approach bridges computational biology, immunology, and pharmacology, contributing to precision medicine and effective TB management. ๐Ÿงช๐Ÿ“Š๐Ÿง  Her research holds promise for developing targeted therapies and improving our understanding of latent TB immune mechanisms.

Publication Top Notes

Identification and assessment of hub genes and miRNAs coregulatory associated with immune infiltrations and drug interactions in latent tuberculosis based on MicroarrayData analysis, molecular docking, and dynamic simulation